IHC
Immunohistochemical analysis of paraffin-embedded Human bladder cancer tissues using CDKN2A antibody with DAB staining.IHC
Immunohistochemical analysis of paraffin-embedded Human breast cancer tissues using CDKN2A antibody with DAB staining.IHC
Immunohistochemical analysis of paraffin-embedded Human esophageal cancer tissues using CDKN2A antibody with DAB staining.IHC
Immunohistochemical analysis of paraffin-embedded Human esophageal tissues using CDKN2A antibody with DAB staining.IHC
Immunohistochemical analysis of paraffin-embedded Human prostate cancer tissues using CDKN2A antibody with DAB staining.| Product Name | Anti-CDKN2A/p19ARF antibody-poly-HRP |
|---|---|
| Antibody Type | Primary Antibodies |
| Immunogen | Polypeptide |
| Conjugation | poly-HRP |
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | IHC |
| IHC:1:100-1:1000 |
|
| Species Reactivity | HumanMouseRat |
| Concentration | 1mg/ml |
| Purification | Protein A |
| Gene Symbol | Cdkn2a |
|---|---|
| Gene Synonyms | Arf p16 MTS1 Pctr1 p19ARF p16INK4a p19 ARF-INK4a INK4a-ARF Ink4a/Arf p16(INK4a) |
| Gene Full Name | cyclin dependent kinase inhibitor 2A |
| Gene Summary | Enables several functions, including DNA-binding transcription activator activity, RNA polymerase II-specific; MDM2/MDM4 family protein binding activity; and enzyme inhibitor activity. Involved in several processes, including cellular response to gamma radiation; negative regulation of lymphocyte proliferation; and positive regulation of apoptotic process. Acts upstream of or within several processes, including keratinocyte proliferation; negative regulation of mammary gland epithelial cell proliferation; and negative regulation of protein metabolic process. Located in cytoplasm and granular component. Part of protein-containing complex. Is expressed in several structures, including central nervous system; eye; genitourinary system; immune system; and umbilical artery. Used to study high grade glioma; malignant peripheral nerve sheath tumor; melanoma (multiple); and pancreatic carcinoma (multiple). Human ortholog(s) of this gene implicated in several diseases, including breast cancer (multiple); carcinoma (multiple); hematologic cancer (multiple); high grade glioma (multiple); and melanoma (multiple). Orthologous to human CDKN2A (cyclin dependent kinase inhibitor 2A). [provided by Alliance of Genome Resources, Apr 2025] |
| Molecular Weight(MW) | 19kDa |
| Source | Rabbit |
| Cellular Localization | Nucleus, Mitochondrion |
| SwissProt ID | Q64364 |
|---|
IHC
Immunohistochemical analysis of paraffin-embedded Human bladder cancer tissues using CDKN2A antibody with DAB staining.
IHC
Immunohistochemical analysis of paraffin-embedded Human breast cancer tissues using CDKN2A antibody with DAB staining.
IHC
Immunohistochemical analysis of paraffin-embedded Human esophageal cancer tissues using CDKN2A antibody with DAB staining.
IHC
Immunohistochemical analysis of paraffin-embedded Human esophageal tissues using CDKN2A antibody with DAB staining.
IHC
Immunohistochemical analysis of paraffin-embedded Human prostate cancer tissues using CDKN2A antibody with DAB staining.| Application Notes | IHC:1:100-1:1000 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | Shipped at 4°C. Store at +4°C short term (1-2 weeks). Store at -20°C long term. Avoid freeze / thaw cycle. |
| Storage Buffer | Purified antibody in PBS with 0.05% sodium azide. |
